Well, it has been quite an anticlimactic day of trading over the first two hours here on Wednesday. The markets are basically flat with the Nasdaq off .2% and the Dow and S&P 500 making minor gains. After Tuesday’s huge…
Read in context ›Corbus Pharmaceuticals Stock (CRBP)
Track Corbus Pharmaceuticals stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
CRBP
Corbus Pharmaceuticals
healthcare
$7.60
▼ -1.67 (-18.09%) past year
Market Cap
$140.07M
P/E Ratio
—
1Y Return
-18.09%
EPS (TTM)
-$5.81
Read the latest TheStreet Pro articles mentioning Corbus Pharmaceuticals, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
5 articlesDaily Diary Mentions
1 mentionThoughts on Google in a Meandering Market